{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-122057","form_type":"8-K","ticker":"CLRB","cik":"0001279704","company_name":"Cellectar Biosciences, Inc.","filed_at":"2023-11-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.514326+00:00","generated_at":"2026-06-07T20:13:25.936173+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Cellectar regains Nasdaq compliance via $35M+ market value of listed securities","bullets":["Nasdaq notified Cellectar on Nov 21, 2023, that it meets the $35M minimum market value of listed securities under Rule 5550(b)(2), resolving the deficiency.","Prior deficiency: stockholders' equity was $(467,000) as of June 30, 2023, below the $2.5M minimum required under Rule 5550(b)(1).","The company had been at risk of delisting since August 16, 2023; compliance is now fully restored."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-122057","json":"https://secwatch.observer/filing/0001104659-23-122057.json","markdown":"https://secwatch.observer/filing/0001104659-23-122057.md","text":"https://secwatch.observer/filing/0001104659-23-122057.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/0001104659-23-122057-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1279704/000110465923122057/tm2331790d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T20:13:25.936173+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}